Jazz Pharmaceuticals’ CBD Drug Hits $1B: Time to Buy the Stock?
JAZZ CBD drug Epidiolex tops $1B in annual sales, boosting revenue visibility and cannabis exposure. Is the biotech’s growth story just beginning?
Beyond CBD: Kyoto Botanicals Launches Sugar-Free Mushroom Brew
(re)GROUND Mushroom + Cacao Adaptogenic Brew is available in a 28-serving jar and is vegan, gluten-free, sugar-free and third-party tested for purity. It is priced at $49 and available at …
Here’s why I wouldn’t touch Tilray with a 10‑foot pole
Tilray Brands is expanding its business at a rapid clip, but there are risks associated with this growth effort.
Global CBD Skin Care Market Projected to Reach USD 58.1 Billion by 2036 Driven by Innovation and Premiumization
The global CBD skincare market will expand from USD 6.6 billion in 2026 to USD 58.1 billion by 2036 | Future Market Insights, Inc. NEWARK, DE / ACCESS Newswire / February 9, 2026 / The global CBD skin …
TruFull CBD Gummies: Product Disclosure Information Updated as CBD Supplement Research Grows in 2026
Examining hemp-derived CBD supplement disclosures, third-party testing verification, THC-free claims, ingredient transparency, refund policies, and what consumers evaluate when researching …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Here’s why I wouldn’t touch Tilray with a 10‑foot pole
Tilray Brands is expanding its business at a rapid clip, but there are risks associated with this growth effort.
Global CBD Skin Care Market Projected to Reach USD 58.1 Billion by 2036 Driven by Innovation and Premiumization
The global CBD skincare market will expand from USD 6.6 billion in 2026 to USD 58.1 billion by 2036 | Future Market Insights, Inc. NEWARK, DE / ACCESS Newswire / February 9, 2026 / The global CBD skin …
TruFull CBD Gummies: Product Disclosure Information Updated as CBD Supplement Research Grows in 2026
Examining hemp-derived CBD supplement disclosures, third-party testing verification, THC-free claims, ingredient transparency, refund policies, and what consumers evaluate when researching …
TruFull CBD Gummies | Launch “CBD Gummies Safe Relieves Anxiety Effective Reduces Pain & Stress With TruFull CBD 2026
A trusted, hemp-based CBD supplement created to help manage stress, and support physical comfort safely.New York City, Feb. 04, 2026 (GLOBE NEWSWIRE) — In today’s fast-paced lifestyle, stress, poor …
cbdMD, Inc. Announces Closing of $2.25 Million Series C Preferred Stock Private Placement
MD, Inc. (NYSE American: YCBD), a leading wellness company and the parent of Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, today announces that it has entered into …
3 Reasons Why CBD Stocks Will Pop in 2026
For years, the CBD market has been growing quietly behind the scenes, building momentum as consumer habits shift toward natural wellness, alternative stress …
Cannabis stocks climb after Trump signs order to ease curbs on marijuana
Cannabis stocks jump as Trump signs executive order to reclassify marijuana, easing federal rules and boosting investment potential.
Trump signs executive order reclassifying cannabis, opening door to broader weed access
Trump’s executive order shifts cannabis from Schedule I to Schedule III, easing research, banking and tax restrictions and marking the biggest federal cannabis policy change in decades. The …
3 penny stocks to watch now, 12/18/25
MD, VYNE Therapeutics, and HeartBeam are the 3 Penny Stocks to watch on December 18, 2025, based on TipRanks’ Penny Stock Screener tool. These …
Recent Comments